Evidence map›Paper›PMID 37442909›Full record

ArticleAnnals of surgical oncology2023

ASO Author Reflections: Characteristics of Surgery for Biliary Tract Cancer that Should be Considered During the Design of Future Clinical Trials.

Shin Kobayashi, Masafumi Ikeda, Kohei Nakachi, Makoto Ueno, Takuji Okusaka, Akiko Todaka, Sohei Satoi, Akira Tomokuni, Masaru Konishi, Junji Furuse

Abstract readComment
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Shin KobayashiDepartment of Hepatobiliary and Pancreatic Surgery, National Cancer Center Hospital East, Kashiwa, Chiba, Japan. shkobaya@east.ncc.go.jp.ORCID 0000-0001-9321-8452
Masafumi IkedaDepartment of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
Kohei NakachiDepartment of Medical Oncology, Tochigi Cancer Center, Tochigi, Japan.
Makoto UenoDepartment of Gastroenterology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
Takuji OkusakaDepartment of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Akiko TodakaDivision of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
Sohei SatoiDepartment of Surgery, Kansai Medical University, Hirakata, Osaka, Japan.
Akira TomokuniDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
Masaru KonishiDepartment of Hepatobiliary and Pancreatic Surgery, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
Junji FuruseDepartment of Gastroenterology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.

Funding

Japan Agency for Medical Research and Development 16ck0106079h0003Japan Agency for Medical Research and Development 17ck0106350h0001Ministry of Health, Labour and Welfare H26-076National Cancer Center Japan 23-A-22National Cancer Center Japan 26-A-4National Cancer Center Japan 29-A-3
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biliary Tract NeoplasmsForecastingHumans

Identifiers

PMID37442909

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.